Skip to main content
. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586
AML acute myeloid leukemia
ASM aggressive systemic mastocytosis
BM bone marrow
CM cutaneous mastocytosis
CMML chronic myelomonocytic leukemia
DCM diffuse cutaneous mastocytosis
HR histamine receptor
IgE immunoglobulin E
ISM indolent systemic mastocytosis
MCL mast cell leukemia
MCS mast cell sarcoma
MPCM maculopapular cutaneous mastocytosis
NB-UVB narrow-band ultraviolet B
NSAIDs nonsteroidal anti-inflammatory drugs
PB peripheral blood
PUVA psoralen plus ultraviolet A
SM systemic mastocytosis
SM-AHN systemic mastocytosis with associated hematologic neoplasm
TKI tyrosine kinase inhibitors
WDSM well-differentiated SM